ALMIB — Amoeba SA Income Statement
0.000.00%
Last trade - 00:00- €53.53m
- €65.14m
Annual income statement for Amoeba SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | -0.35 | -0.358 | -0.366 | -0.459 | -0.286 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6.16 | 5.58 | 6.15 | 14 | 5.66 |
| Operating Profit | -6.16 | -5.58 | -6.15 | -14 | -5.66 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -8.16 | -7.82 | -8.02 | -14.3 | -6.59 |
| Net Income After Taxes | -8.16 | -7.82 | -8.02 | -14.3 | -6.59 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -8.16 | -7.82 | -8.02 | -14.3 | -6.59 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -8.16 | -7.82 | -8.02 | -14.3 | -6.59 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.503 | -0.44 | -0.23 | -0.19 | -0.133 |
| Dividends per Share |